Are FDA and CE sacrificing safety for a faster commercialization of xenogeneic tissue devices? Unavoidable need for legislation in decellularized tissue manufacturing
Naso, F., Iop, L., Spina, M., Gerosa, G.Volume:
83
Language:
english
Journal:
Tissue Antigens
DOI:
10.1111/tan.12275
Date:
March, 2014
File:
PDF, 449 KB
english, 2014